Picard Medical, Inc.
About Picard Medical, Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $4.9M
- Net income
- -$27.0M
- Total assets
- $22.5M
- Market cap
- $24.1M
- Gross margin
- -4.1%
- Operating margin
- -268.4%
- Net margin
- -546.6%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $4.9M
- Cost of revenue
- $5.1M
- Gross profit
- -$204.0K
- Operating expenses
- $13.1M
- Operating income
- -$13.3M
- Income tax
- $35.0K
- Net income
- -$27.0M
- EPS (basic)
- $-0.75
Balance sheet
- Total assets
- $22.5M
- Current assets
- $20.7M
- Total liabilities
- $18.8M
- Current liabilities
- $18.7M
- Shareholders’ equity
- $3.8M
Cash flow
- Operating cash flow
- -$15.7M
- Investing cash flow
- -$11.4M
- Financing cash flow
- $27.1M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
- Market cap
- $24.1M
- Dividend yield
- 3.85%
- Shares outstanding
- 92.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 29, 2025
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $27.0M in FY2025.
- Gross margin of -4.1%, net margin -546.6%.
- Trading 98% below its 52-week high.
- Pays a dividend yielding about 3.85% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Picard Medical, Inc..
Write a review
News about Picard Medical, Inc.
News & sentiment via Polygon.io
